Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Compare complete versions: U.S. labeling uses 2-hour infusions, while UCSF uses 3-hour extended infusions. Nebraska separately lists an HD/PD interval different from the label. Do not select a dose from one version and an interval from another.
Check source scope before reading a dose
Nebraska Medicine - AVYCAZ renal and HD/PD schedule
Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method
Adult CrCl estimate mL/min; dialysis row is separate
Source revision
Retrieved PDF page 14; revision date not independently established
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Professional
Nebraska Medicine - AVYCAZ renal and HD/PD schedule
Nebraska Medicine / UNMC · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method: Adult CrCl estimate mL/min; dialysis row is separate Source date: Retrieved PDF page 14; revision date not independently established Retrieved: 2026-09-05
Source recheck unresolved. Prior follow-up retrieval/version warning retained; not resolved by v6.0. Read source-review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
Adult baseline 2.5 g IV every 8 hours; all doses over 2 hours. CrCl 31-50: 1.25 g every 8 hours; 16-30: 0.94 g every 12 hours; 6-15: 0.94 g daily; <=5: 0.94 g every 48 hours. The separate HD/PD row uses 0.94 g daily with limited data, after dialysis on HD days. This dialysis interval differs from the U.S. label and is not silently reconciled.
RDM30-107-ceftazidime-avibactam-1 · Source locator: Nebraska Medicine - AVYCAZ renal and HD/PD schedule; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.